WAIKOLOA, HAWAII – The 2014 update of the American Academy of Dermatology guidelines on atopic dermatitis take a strong stance in favor of the use of topical calcineurin inhibitors as topical...
Roughly half of psoriasis patients on adalimumab showed complete resolution in specific body regions after 16 weeks, according to an analysis of the phase III CHAMPION trial reported in the May issue...
Patients who survived Stevens-Johnson syndrome or toxic epidermal necrolysis had a 7% incidence of recurrence, based on data from a 10-year population study of more than 500 Canadian patients.
The...
The Food and Drug Administration is requiring all tanning beds to carry a "black box" warning that the devices should not be used by children under age 18 years.
The labeling doesn’t...
Four confirmed and nine suspected cases of invasive group A Streptococcus infection, including one fatality, developed after liposuction at a chain of "medical spas" in Maryland and...
Dalbavancin is the first drug with a Qualified Infectious Disease Product designation to be approved by the Food and Drug Administration.
On May 23, the agency approved dalbavancin (<link...
WAIKOLOA, HAWAII – Fresh approaches for treating atopic dermatitis are sorely needed, and several intriguing novel therapies are under study, according to Dr. Wynnis Tom.
While topical...
DENVER – As the nanotechnology field evolves, there are at least three reasons a clinician might prefer to use nanoparticles over conventional drugs, according to Dr. Jack L. Arbiser. The first is to...
An analysis of 20 sunscreens by Consumer Reports found that only two provided the SPF protection claimed on the label.
The analysis – and rating of overall performance of those sunscreens – was...
WAIKOLOA, HAWAII – The spectacular developments in the treatment of advanced melanoma that began with approval of ipilimumab in 2011 continue to accelerate, and these advances promise to keep...